|
JPS59204036A
(ja)
|
1983-05-06 |
1984-11-19 |
Dainippon Ink & Chem Inc |
レジストパタ−ンの形成法
|
|
US4981784A
(en)
|
1987-12-02 |
1991-01-01 |
The Salk Institute For Biological Studies |
Retinoic acid receptor method
|
|
US5171671A
(en)
|
1987-12-02 |
1992-12-15 |
The Salk Institute For Biological Studies |
Retinoic acid receptor composition
|
|
US5906936A
(en)
|
1988-05-04 |
1999-05-25 |
Yeda Research And Development Co. Ltd. |
Endowing lymphocytes with antibody specificity
|
|
US5602009A
(en)
|
1988-12-23 |
1997-02-11 |
The Salk Institute For Biological Studies |
Dominant negative chimeras of the steroid/thyroid superfamily of receptors
|
|
US5164897A
(en)
|
1989-06-21 |
1992-11-17 |
Techpower, Inc. |
Automated method for selecting personnel matched to job criteria
|
|
ES2152920T3
(es)
|
1990-02-09 |
2001-02-16 |
Salk Inst For Biological Studi |
Composiciones receptoras de retinoides y metodos.
|
|
DE69131718T2
(de)
|
1990-12-21 |
2000-03-02 |
The Rockefeller University, New York |
Aus leber angereicherter transkriptionsfaktor
|
|
US5851828A
(en)
|
1991-03-07 |
1998-12-22 |
The General Hospital Corporation |
Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells
|
|
US5843728A
(en)
|
1991-03-07 |
1998-12-01 |
The General Hospital Corporation |
Redirection of cellular immunity by receptor chimeras
|
|
US6004811A
(en)
|
1991-03-07 |
1999-12-21 |
The Massachussetts General Hospital |
Redirection of cellular immunity by protein tyrosine kinase chimeras
|
|
US5912170A
(en)
|
1991-03-07 |
1999-06-15 |
The General Hospital Corporation |
Redirection of cellular immunity by protein-tyrosine kinase chimeras
|
|
US7049136B2
(en)
|
1991-03-07 |
2006-05-23 |
The General Hospital Corporation |
Redirection of cellular immunity by receptor chimeras
|
|
US6090914A
(en)
|
1991-06-27 |
2000-07-18 |
Bristol-Myers Squibb Company |
CTLA4/CD28Ig hybrid fusion proteins and uses thereof
|
|
US6887471B1
(en)
|
1991-06-27 |
2005-05-03 |
Bristol-Myers Squibb Company |
Method to inhibit T cell interactions with soluble B7
|
|
EP0531256B1
(de)
|
1991-09-04 |
1997-04-23 |
Novartis AG |
Verfahren zur Herstellung von Glykosiden
|
|
CA2115452A1
(en)
|
1991-09-17 |
1993-04-01 |
Ronald M. Evans |
Receptor of the thyroid/steroid hormone receptor superfamily
|
|
IL104570A0
(en)
|
1992-03-18 |
1993-05-13 |
Yeda Res & Dev |
Chimeric genes and cells transformed therewith
|
|
US5789187A
(en)
|
1992-08-27 |
1998-08-04 |
Worcester Foundation For Experimental Biology |
Identification of differentiation factor receptors which inhibit the tumorigenicity of neuroblastoma cells in a ligand-independent manner
|
|
US5552303A
(en)
|
1993-03-08 |
1996-09-03 |
Immunex Corporation |
DNA encoding epithelium-derived T-cell factor
|
|
JPH08511000A
(ja)
|
1993-04-06 |
1996-11-19 |
フレッド ハッチンソン キャンサー リサーチ センター |
リンパ球におけるキメラサイトカインレセプター
|
|
IL110298A
(en)
|
1993-07-13 |
1999-04-11 |
Brann Mark Robert |
Identification of ligands by selective amplification of cells transfected with receptors
|
|
CA2204183A1
(en)
|
1994-11-01 |
1996-05-09 |
Andrew Lawrence Feldhaus |
Chimeric receptors for the generation of selectively-activatable th-independent cytotoxic t cells
|
|
US6005086A
(en)
|
1995-01-13 |
1999-12-21 |
The Salk Institute For Biological Studies |
Farnesoid activated receptor polypeptides, and nucleic acid encoding the same
|
|
US5935821A
(en)
|
1995-01-17 |
1999-08-10 |
Board Of Trustees Of The University Of Kentucky |
Polynucleotides related to monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
|
|
US5712149A
(en)
|
1995-02-03 |
1998-01-27 |
Cell Genesys, Inc. |
Chimeric receptor molecules for delivery of co-stimulatory signals
|
|
US6103521A
(en)
|
1995-02-06 |
2000-08-15 |
Cell Genesys, Inc. |
Multispecific chimeric receptors
|
|
ES2308779T3
(es)
|
1995-07-26 |
2008-12-01 |
Astrazeneca Ab |
Receptores quimericos y metodos para identificar compuestos activos en los receptores de glutamato metabotropico y el uso de tales compuestos en el tratamiento de trastornos y enfermedades neurologicas.
|
|
US5750353A
(en)
|
1995-12-11 |
1998-05-12 |
New England Medical Center Hospitals, Inc. |
Assay for non-peptide agonists to peptide hormone receptors
|
|
US6084084A
(en)
|
1996-02-21 |
2000-07-04 |
Nps Pharmaceuticals, Inc. |
Human metabotropic glutamate receptor
|
|
WO1997041232A1
(en)
|
1996-04-26 |
1997-11-06 |
Beth Israel Deaconess Medical Center |
Antagonists of interleukin-15
|
|
US6451308B1
(en)
|
1996-04-26 |
2002-09-17 |
Beth Israel Deaconess Medical Center |
Antagonists of interleukin-15
|
|
US7196164B2
(en)
|
1997-07-08 |
2007-03-27 |
Human Genome Sciences, Inc. |
Secreted protein HHTLF25
|
|
US6120669A
(en)
|
1997-04-16 |
2000-09-19 |
Drexel University |
Bipolar electrochemical connection of materials
|
|
ATE323756T1
(de)
|
1997-04-30 |
2006-05-15 |
Hans Klingemann |
Natürliche killerzelllinien und verfahren zu ihrer verwendung
|
|
EP1000084A4
(en)
|
1997-07-08 |
2003-03-26 |
Human Genome Sciences Inc |
123 HUMAN SECRETED PROTEINS
|
|
US6416973B1
(en)
|
1997-08-01 |
2002-07-09 |
Schering Corporation |
Nucleic acids encoding mammalian cell membrane protein MDL-1
|
|
US6607879B1
(en)
|
1998-02-09 |
2003-08-19 |
Incyte Corporation |
Compositions for the detection of blood cell and immunological response gene expression
|
|
US7001733B1
(en)
|
1998-05-12 |
2006-02-21 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions for screening for modulations of IgE synthesis, secretion and switch rearrangement
|
|
US6410319B1
(en)
|
1998-10-20 |
2002-06-25 |
City Of Hope |
CD20-specific redirected T cells and their use in cellular immunotherapy of CD20+ malignancies
|
|
US6307024B1
(en)
|
1999-03-09 |
2001-10-23 |
Zymogenetics, Inc. |
Cytokine zalpha11 Ligand
|
|
WO2000063374A1
(en)
|
1999-04-16 |
2000-10-26 |
Celltech Therapeutics Limited |
Synthetic transmembrane components
|
|
US6747665B1
(en)
|
1999-05-10 |
2004-06-08 |
Ge Medical Systems Global Technology Company, Llc |
Semi-transparent medical image overlays
|
|
US6361714B1
(en)
|
1999-06-03 |
2002-03-26 |
Fuji Photo Film Co., Ltd. |
Method of preparing barium fluorohalide phosphor
|
|
WO2001026608A2
(en)
|
1999-10-14 |
2001-04-19 |
Ledbetter Jeffrey A |
Dna vaccines encoding antigen linked to a domain that binds cd40
|
|
EP1284747A2
(en)
|
2000-05-12 |
2003-02-26 |
Beth Israel Deaconess Medical Center, Inc. |
Compositions and methods for achieving immune suppression
|
|
GB0017173D0
(en)
|
2000-07-12 |
2000-08-30 |
Bp Chem Int Ltd |
Process for the production of olefins
|
|
JP4908721B2
(ja)
|
2000-07-17 |
2012-04-04 |
中外製薬株式会社 |
生理活性を有するリガンドのスクリーニング方法
|
|
EP1349873B1
(en)
|
2000-09-14 |
2009-04-01 |
Beth Israel Deaconess Medical Center, Inc. |
Modulation of il-2- and il-15-mediated t cell responses
|
|
GB0025307D0
(en)
|
2000-10-16 |
2000-11-29 |
Celltech Chiroscience Ltd |
Biological products
|
|
US20020102264A1
(en)
|
2000-10-18 |
2002-08-01 |
Cheung Nai-Kong V. |
Uses of monoclonal antibody 8H9
|
|
US6937446B2
(en)
|
2000-10-20 |
2005-08-30 |
Kabushiki Kaisha Toshiba |
Magnetoresistance effect element, magnetic head and magnetic recording and/or reproducing system
|
|
EP1356066A2
(en)
|
2000-10-24 |
2003-10-29 |
Syngenta Participations AG |
Control of gene expression in plants
|
|
ATE338124T1
(de)
|
2000-11-07 |
2006-09-15 |
Hope City |
Cd19-spezifische umgezielte immunzellen
|
|
US6706867B1
(en)
|
2000-12-19 |
2004-03-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
DNA array sequence selection
|
|
WO2002066618A1
(en)
|
2001-02-20 |
2002-08-29 |
University Of Georgia Research Foundation, Inc. |
Rapid production of monoclonal antibodies
|
|
US7723111B2
(en)
|
2001-03-09 |
2010-05-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Activated dual specificity lymphocytes and their methods of use
|
|
US7070995B2
(en)
|
2001-04-11 |
2006-07-04 |
City Of Hope |
CE7-specific redirected immune cells
|
|
US7514537B2
(en)
|
2001-04-30 |
2009-04-07 |
City Of Hope |
Chimeric immunoreceptor useful in treating human gliomas
|
|
US6824974B2
(en)
|
2001-06-11 |
2004-11-30 |
Genorx, Inc. |
Electronic detection of biological molecules using thin layers
|
|
US20030148982A1
(en)
|
2001-11-13 |
2003-08-07 |
Brenner Malcolm K. |
Bi-spcific chimeric T cells
|
|
JP3749873B2
(ja)
|
2002-03-28 |
2006-03-01 |
株式会社東芝 |
磁気抵抗効果素子、磁気ヘッド及び磁気再生装置
|
|
US8535672B2
(en)
|
2002-04-04 |
2013-09-17 |
Yissum Research Development Of The Hebrew University Of Jerusalem |
Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between CD28 and the superantigen and uses thereof
|
|
DE60327199D1
(de)
|
2002-04-26 |
2009-05-28 |
Chugai Pharmaceutical Co Ltd |
Verfahren zum screening auf agonistische antikörper
|
|
US7446190B2
(en)
|
2002-05-28 |
2008-11-04 |
Sloan-Kettering Institute For Cancer Research |
Nucleic acids encoding chimeric T cell receptors
|
|
US8263375B2
(en)
|
2002-12-20 |
2012-09-11 |
Acea Biosciences |
Dynamic monitoring of activation of G-protein coupled receptor (GPCR) and receptor tyrosine kinase (RTK) in living cells using real-time microelectronic cell sensing technology
|
|
CA2501870C
(en)
|
2002-10-09 |
2013-07-02 |
Avidex Limited |
Single chain recombinant t cell receptors
|
|
JP3836788B2
(ja)
|
2002-12-26 |
2006-10-25 |
株式会社東芝 |
磁気抵抗効果素子、磁気抵抗効果型ヘッドおよび磁気記録再生装置
|
|
US7468248B2
(en)
|
2002-12-31 |
2008-12-23 |
Cargill, Incorporated |
Methods and systems for inferring bovine traits
|
|
US7527944B2
(en)
|
2003-06-27 |
2009-05-05 |
Monell Chemical Senses Center |
Taste receptors of the T1R family from domestic cat
|
|
KR20130065723A
(ko)
|
2003-06-27 |
2013-06-19 |
암젠 프레몬트 인코포레이티드 |
상피 성장 인자 수용체의 결실 돌연변이체 지향 항체 및 그 용도
|
|
DE602004027048D1
(de)
*
|
2003-07-16 |
2010-06-17 |
Resverlogix Inc |
Verbindungen und methoden für das downregulating der effekte von tgf-beta
|
|
US20130266551A1
(en)
|
2003-11-05 |
2013-10-10 |
St. Jude Children's Research Hospital, Inc. |
Chimeric receptors with 4-1bb stimulatory signaling domain
|
|
US7435596B2
(en)
|
2004-11-04 |
2008-10-14 |
St. Jude Children's Research Hospital, Inc. |
Modified cell line and method for expansion of NK cell
|
|
US7089052B2
(en)
|
2004-02-26 |
2006-08-08 |
Tanita Corporation |
Method and system for estimating visceral fat area
|
|
ES2425749T3
(es)
|
2004-03-31 |
2013-10-17 |
The General Hospital Corporation |
Método para determinar la respuesta del cáncer a tratamientos dirigidos al receptor del factor de crecimiento epidérmico
|
|
SI1674111T1
(sl)
|
2004-07-09 |
2011-02-28 |
Chugai Pharmaceutical Co Ltd |
Protitelo proti glipikanu 3
|
|
FR2873813B1
(fr)
|
2004-07-30 |
2006-11-17 |
Abx Sa |
Procede et dispositif de caracterisation des composants cellulaires d'un liquide biologique
|
|
ATE453716T1
(de)
|
2004-08-03 |
2010-01-15 |
Geneart Ag |
Verfahren zur modulation der genexpression durch änderung des cpg gehalts
|
|
US7235190B1
(en)
|
2004-09-02 |
2007-06-26 |
Sandia Corporation |
Nanocluster-based white-light-emitting material employing surface tuning
|
|
AU2005336093B2
(en)
|
2004-10-08 |
2011-02-24 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Adoptive immunotherapy with enhanced T lymphocyte survival
|
|
US7485600B2
(en)
|
2004-11-17 |
2009-02-03 |
Honda Motor Co., Ltd. |
Catalyst for synthesis of carbon single-walled nanotubes
|
|
US7700728B2
(en)
|
2005-03-24 |
2010-04-20 |
Schering Corporation |
Use of chimeric receptors in a screening assay for identifying agonists and antagonists of cell receptors
|
|
EP3263581B2
(en)
|
2005-05-17 |
2025-07-09 |
University of Connecticut |
Compositions and methods for immunomodulation in an organism
|
|
WO2006133398A2
(en)
|
2005-06-08 |
2006-12-14 |
Invitrogen Corporation |
In vitro activated donor t-cells to promote transplant engraftment
|
|
WO2007002905A1
(en)
|
2005-06-29 |
2007-01-04 |
University Of Miami |
Antibody-immune cell ligand fusion protein for cancer therapy
|
|
ES2373055T3
(es)
|
2005-08-09 |
2012-01-31 |
Oncotherapy Science, Inc. |
Péptido antígeno de rechazo de cáncer derivado de glipican-3 (gpc3) para uso en pacientes positivos a la hla-a2 y producto farmacéutico que comprende el antígeno.
|
|
US7341944B2
(en)
|
2005-09-15 |
2008-03-11 |
Honda Motor Co., Ltd |
Methods for synthesis of metal nanowires
|
|
KR20080080525A
(ko)
|
2005-12-08 |
2008-09-04 |
노파르티스 아게 |
유전자 전사에 대한 ｆｇｆｒ３의 억제제의 효과
|
|
NZ569541A
(en)
|
2006-01-13 |
2012-05-25 |
Us Gov Health & Human Serv |
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
|
|
ES2374458T3
(es)
|
2006-01-13 |
2012-02-16 |
The Trustees Of The University Of Pennsylvania |
Vacunas y agentes inmunoterapéuticos que utilizan il-15 optimizada en codones, y métodos para utilización de los mismos.
|
|
WO2007121604A2
(en)
|
2006-04-20 |
2007-11-01 |
Givaudan Sa |
Method relating to sweetness enhancement
|
|
JP5300184B2
(ja)
|
2006-07-18 |
2013-09-25 |
キヤノン株式会社 |
圧電体、圧電体素子、圧電体素子を用いた液体吐出ヘッド及び液体吐出装置
|
|
US7972438B2
(en)
|
2006-08-30 |
2011-07-05 |
Crystal Photonics, Incorporated |
High-index UV optical materials for immersion lithography
|
|
RU2495882C2
(ru)
|
2006-09-08 |
2013-10-20 |
Медиммун, Ллк. |
Гуманизированные антитела к cd19 и их применение для лечения онкологического, связанного с трансплантацией и аутоиммунного заболевания
|
|
WO2008045437A2
(en)
|
2006-10-09 |
2008-04-17 |
The General Hospital Corporation |
Chimeric t-cell receptors and t-cells targeting egfrviii on tumors
|
|
WO2008060510A2
(en)
*
|
2006-11-13 |
2008-05-22 |
Sangamo Biosciences, Inc. |
Zinc finger nuclease for targeting the human glucocorticoid receptor locus
|
|
EP2413142B1
(en)
|
2007-02-27 |
2013-06-05 |
Nuclea Biomarkers LLC |
Method for predicting the response of NSCLC-patients to treatment by an EGFR-TK inhibitor
|
|
US8053615B2
(en)
|
2007-03-08 |
2011-11-08 |
Virent Energy Systems, Inc. |
Synthesis of liquid fuels and chemicals from oxygenated hydrocarbons
|
|
WO2008112886A1
(en)
|
2007-03-13 |
2008-09-18 |
Evident Technologies, Inc. |
Infrared display with luminescent quantum dots
|
|
SI2856876T1
(en)
|
2007-03-30 |
2018-04-30 |
Memorial Sloan-Kettering Cancer Center |
Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
|
|
US8163279B2
(en)
|
2007-04-13 |
2012-04-24 |
Stemline Therapeutics, Inc. |
IL3Rα antibody conjugates and uses thereof
|
|
WO2008154738A1
(en)
|
2007-06-18 |
2008-12-24 |
Universite De Montreal |
Azapeptides as cd36 binding compounds
|
|
NZ599338A
(en)
|
2007-06-27 |
2013-11-29 |
Marinepolymer Tech Inc |
Complexes of il-15 and il-15ralpha and uses thereof
|
|
EP2048237A1
(en)
|
2007-10-05 |
2009-04-15 |
Avir Green Hills Biotechnology Research Development Trade Ag |
Replication deficient Influenza virus for the expression of heterologous sequences
|
|
US8329421B2
(en)
|
2007-07-13 |
2012-12-11 |
Ventana Medical Systems, Inc. |
Methods of predicting response of a neoplasm to an EGFR inhibitor and detecting interactions between EGFR and an EGFR regulatory protein
|
|
US8900816B2
(en)
|
2007-07-19 |
2014-12-02 |
Duke University |
Assay for anti-EGFRvIII antibodies
|
|
DK2211904T3
(en)
|
2007-10-19 |
2016-10-24 |
Seattle Genetics Inc |
Cd19-binding agents and uses thereof
|
|
US8450112B2
(en)
|
2008-04-09 |
2013-05-28 |
Maxcyte, Inc. |
Engineering and delivery of therapeutic compositions of freshly isolated cells
|
|
US8591858B2
(en)
|
2008-05-01 |
2013-11-26 |
Honda Motor Co., Ltd. |
Effect of hydrocarbon and transport gas feedstock on efficiency and quality of grown single-walled nanotubes
|
|
EP2331566B1
(en)
|
2008-08-26 |
2015-10-07 |
City of Hope |
Method and compositions for enhanced anti-tumor effector functioning of t cells
|
|
EP2331486A2
(en)
|
2008-08-27 |
2011-06-15 |
Virent Energy Systems Inc. |
Synthesis of liquid fuels from biomass
|
|
RU2573912C2
(ru)
|
2008-10-08 |
2016-01-27 |
Интрексон Корпорейшн |
Сконструированные клетки, экспрессирующие множественные иммуномодуляторы, и их применения
|
|
EP2344636B1
(en)
|
2008-10-09 |
2017-12-06 |
Howard Hughes Medical Institute |
Novel chimeric ligand-gated ion channels and methods of use thereof
|
|
CN102421800A
(zh)
|
2009-02-23 |
2012-04-18 |
格兰马克药品股份有限公司 |
结合cd19的人源化抗体及其用途
|
|
WO2010132532A1
(en)
|
2009-05-15 |
2010-11-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
B cell surface reactive antibodies
|
|
IT1394774B1
(it)
|
2009-06-04 |
2012-07-13 |
Univ Roma |
Costrutti esprimenti recettori chimerici, e loro uso per l'attivazione controllata delle risposte di difesa a organismi patogeni in piante
|
|
ES2598005T3
(es)
|
2009-08-14 |
2017-01-24 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Uso de IL-15 para aumentar la salida del timo y para tratar la linfopenia
|
|
CA2776143A1
(en)
|
2009-10-01 |
2011-04-07 |
The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services |
Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer
|
|
WO2011059836A2
(en)
|
2009-10-29 |
2011-05-19 |
Trustees Of Dartmouth College |
T cell receptor-deficient t cell compositions
|
|
US9273283B2
(en)
|
2009-10-29 |
2016-03-01 |
The Trustees Of Dartmouth College |
Method of producing T cell receptor-deficient T cells expressing a chimeric receptor
|
|
TR201904484T4
(tr)
|
2009-11-03 |
2019-05-21 |
Hope City |
Transdüse T hücre seçimine yönelik kesik epiderimal büyüme faktörü reseptörü (EGFRt).
|
|
CN102753574B
(zh)
|
2009-12-11 |
2015-05-20 |
西马生物医学计划公司 |
用于免疫治疗和抗肿瘤治疗的缀合物和组合物
|
|
CA3255551A1
(en)
|
2010-03-26 |
2025-04-15 |
Memorial Sloan-Kettering Cancer Center |
MUC16 ANTIBODIES AND METHODS OF USE
|
|
WO2011130491A2
(en)
|
2010-04-14 |
2011-10-20 |
Roger Williams Medical Center |
Methods and compositions for treating hiv
|
|
EP2566954B2
(en)
|
2010-05-04 |
2022-11-02 |
Yeda Research and Development Co. Ltd. |
Immunotherapy using redirected allogeneic cells
|
|
US9089520B2
(en)
|
2010-05-21 |
2015-07-28 |
Baylor College Of Medicine |
Methods for inducing selective apoptosis
|
|
EP3323830B1
(en)
|
2010-06-19 |
2023-08-23 |
Memorial Sloan-Kettering Cancer Center |
Anti-gd2 antibodies
|
|
US9163258B2
(en)
|
2010-07-23 |
2015-10-20 |
Fred Hutchinson Cancer Research Center |
Method for the treatment of obesity
|
|
WO2012033885A1
(en)
|
2010-09-08 |
2012-03-15 |
Baylor College Of Medicine |
Immunotherapy of cancer using genetically engineered gd2-specific t cells
|
|
WO2012136231A1
(en)
|
2010-09-08 |
2012-10-11 |
Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus |
Interleukin 15 as selectable marker for gene transfer in lymphocytes
|
|
ES2602743T3
(es)
|
2010-09-08 |
2017-02-22 |
Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus |
Receptores de antígenos quiméricos con una región bisagra optimizada
|
|
US9845362B2
(en)
|
2010-10-08 |
2017-12-19 |
The University Of North Carolina At Charlotte |
Compositions comprising chimeric antigen receptors, T cells comprising the same, and methods of using the same
|
|
CN102443056B
(zh)
|
2010-10-15 |
2015-04-29 |
上海市肿瘤研究所 |
表皮生长因子受体的外显子缺失变异体
|
|
US9518132B2
(en)
|
2010-11-09 |
2016-12-13 |
Altimab Therapeutics, Inc. |
Protein complexes for antigen binding and methods of use
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
US9233125B2
(en)
|
2010-12-14 |
2016-01-12 |
University Of Maryland, Baltimore |
Universal anti-tag chimeric antigen receptor-expressing T cells and methods of treating cancer
|
|
CA2820753C
(en)
|
2010-12-30 |
2020-12-01 |
Virent, Inc. |
Organo-catalytic biomass deconstruction
|
|
KR20140004174A
(ko)
|
2011-01-18 |
2014-01-10 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
암 치료를 위한 조성물 및 방법
|
|
EP2673300B1
(en)
|
2011-02-11 |
2016-08-24 |
Memorial Sloan-Kettering Cancer Center |
Hla-restricted, peptide-specific antigen binding proteins
|
|
US9987308B2
(en)
|
2011-03-23 |
2018-06-05 |
Fred Hutchinson Cancer Research Center |
Method and compositions for cellular immunotherapy
|
|
CA2832540C
(en)
|
2011-04-08 |
2020-09-15 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer
|
|
CN103502439B
(zh)
|
2011-04-13 |
2016-10-12 |
因缪尼卡姆股份公司 |
用于抗原特异性t细胞增殖的方法
|
|
EP2699603B1
(en)
|
2011-04-19 |
2016-03-02 |
The United States of America As Represented by the Secretary Department of Health and Human Services |
Human monoclonal antibodies specific for glypican-3 and use thereof
|
|
US20130001376A1
(en)
|
2011-06-28 |
2013-01-03 |
F2M International Inc. |
Hose hanger
|
|
US9685295B2
(en)
|
2011-07-28 |
2017-06-20 |
The Board Of Trustees Of The University Of Illinois |
Electron emission device
|
|
EP2744870B1
(en)
|
2011-08-16 |
2017-11-22 |
Nitto Denko Corporation |
Phosphor compositions and methods of making the same
|
|
WO2013033626A2
(en)
|
2011-08-31 |
2013-03-07 |
Trustees Of Dartmouth College |
Nkp30 receptor targeted therapeutics
|
|
EP3326467B1
(en)
|
2011-09-16 |
2020-03-11 |
Baylor College of Medicine |
Targeting the tumor microenvironment using manipulated nkt cells
|
|
WO2013044225A1
(en)
|
2011-09-22 |
2013-03-28 |
The Trustees Of The University Of Pennsylvania |
A universal immune receptor expressed by t cells for the targeting of diverse and multiple antigens
|
|
WO2013051718A1
(ja)
|
2011-10-07 |
2013-04-11 |
国立大学法人三重大学 |
キメラ抗原受容体
|
|
ES2654060T3
(es)
|
2011-10-20 |
2018-02-12 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Receptores de antígenos quiméricos anti-CD22
|
|
US9688740B2
(en)
|
2011-10-26 |
2017-06-27 |
National Cancer Center |
Mutant CTLA4 gene transfected T cell and composition including same for anticancer immunotherapy
|
|
US9272002B2
(en)
|
2011-10-28 |
2016-03-01 |
The Trustees Of The University Of Pennsylvania |
Fully human, anti-mesothelin specific chimeric immune receptor for redirected mesothelin-expressing cell targeting
|
|
US9422351B2
(en)
|
2011-11-03 |
2016-08-23 |
The Trustees Of The University Of Pennsylvania |
Isolated B7-H4 specific compositions and methods of use thereof
|
|
WO2013070468A1
(en)
|
2011-11-08 |
2013-05-16 |
The Trustees Of The University Of Pennsylvania |
Glypican-3-specific antibody and uses thereof
|
|
US9422360B2
(en)
|
2011-12-19 |
2016-08-23 |
Zhonghao Chenguang Research Institute Of Chemical Industry Company Limited |
Porcine CD28 receptor, gene for encoding same, and application of same
|
|
CA2848985A1
(en)
|
2012-02-01 |
2013-08-08 |
Compugen Ltd. |
C10rf32 antibodies, and uses thereof for treatment of cancer
|
|
CA2861491C
(en)
|
2012-02-13 |
2020-08-25 |
Seattle Children's Hospital D/B/A Seattle Children's Research Institute |
Bispecific chimeric antigen receptors and therapeutic uses thereof
|
|
EP2817330B1
(en)
|
2012-02-22 |
2020-07-08 |
The Trustees of the University of Pennsylvania |
Use of icos-based cars to enhance antitumor activity and car persistence
|
|
CA3285826A1
(en)
|
2012-02-22 |
2026-03-02 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for generating a persisting population of t cells useful for the treatment of cancer
|
|
WO2013126729A1
(en)
|
2012-02-22 |
2013-08-29 |
The Trustees Of The University Of Pennsylvania |
Use of the cd2 signaling domain in second-generation chimeric antigen receptors
|
|
EP2828290B1
(en)
|
2012-03-23 |
2018-08-15 |
The United States of America, represented by the Secretary, Department of Health and Human Services |
Anti-mesothelin chimeric antigen receptors
|
|
RU2766608C2
(ru)
|
2012-04-11 |
2022-03-15 |
Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез |
Химерные антигенные рецепторы, нацеленные на антиген созревания b-клеток
|
|
US9156915B2
(en)
|
2012-04-26 |
2015-10-13 |
Thomas Jefferson University |
Anti-GCC antibody molecules
|
|
WO2013169691A1
(en)
|
2012-05-07 |
2013-11-14 |
Trustees Of Dartmouth College |
Anti-b7-h6 antibody, fusion proteins, and methods of using the same
|
|
BR112014029417B1
(pt)
|
2012-05-25 |
2023-03-07 |
Cellectis |
Método ex vivo para a preparação de células t para imunoterapia
|
|
IN2015MN00001A
(https=)
|
2012-06-08 |
2015-10-16 |
Univ Kinki |
|
|
JP6482461B2
(ja)
|
2012-07-13 |
2019-03-13 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
投与に関する形質導入ｔ細胞の適合性の評価方法
|
|
WO2014055442A2
(en)
|
2012-10-01 |
2014-04-10 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for targeting stromal cells for the treatment of cancer
|
|
AU2013329186B2
(en)
|
2012-10-10 |
2019-02-14 |
Sangamo Therapeutics, Inc. |
T cell modifying compounds and uses thereof
|
|
RU2658485C2
(ru)
|
2012-10-24 |
2018-06-21 |
Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез |
Химерные антигенные рецепторы м971
|
|
EP2948544A4
(en)
|
2013-01-28 |
2016-08-03 |
St Jude Childrens Res Hospital |
CHIMERIC RECEPTOR WITH NKG2D SPECIFICITY FOR CELL THERAPY AGAINST CANCER AND INFECTION DISEASES
|
|
CN113005091A
(zh)
|
2013-02-06 |
2021-06-22 |
细胞基因公司 |
具有改进特异性的修饰的t淋巴细胞
|
|
JO3529B1
(ar)
|
2013-02-08 |
2020-07-05 |
Amgen Res Munich Gmbh |
مضاد التصاق خلايا الدم البيض من أجل التخفيف من الاثار السلبية الممكنة الناتجة عن مجالات ارتباط cd3- المحدد
|
|
DK2956175T3
(da)
|
2013-02-15 |
2017-11-27 |
Univ California |
Kimærisk antigenreceptor og fremgangsmåder til anvendelse deraf
|
|
JP6647868B2
(ja)
|
2013-02-20 |
2020-02-14 |
ノバルティス アーゲー |
ヒト化抗ＥＧＦＲｖＩＩＩキメラ抗原受容体を用いたがんの処置
|
|
US9573988B2
(en)
|
2013-02-20 |
2017-02-21 |
Novartis Ag |
Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells
|
|
WO2014138314A1
(en)
|
2013-03-05 |
2014-09-12 |
Baylor College Of Medicine |
Oncolytic virus
|
|
US9434935B2
(en)
|
2013-03-10 |
2016-09-06 |
Bellicum Pharmaceuticals, Inc. |
Modified caspase polypeptides and uses thereof
|
|
IL311390A
(en)
*
|
2013-03-15 |
2024-05-01 |
Memorial Sloan Kettering Cancer Center |
Preparations and methods for immunotherapy
|
|
US9393268B2
(en)
|
2013-03-15 |
2016-07-19 |
Thomas Jefferson University |
Cell-based anti-cancer compositions with reduced toxicity and methods of making and using the same
|
|
US9446105B2
(en)
|
2013-03-15 |
2016-09-20 |
The Trustees Of The University Of Pennsylvania |
Chimeric antigen receptor specific for folate receptor β
|
|
US9657105B2
(en)
|
2013-03-15 |
2017-05-23 |
City Of Hope |
CD123-specific chimeric antigen receptor redirected T cells and methods of their use
|
|
WO2014145252A2
(en)
|
2013-03-15 |
2014-09-18 |
Milone Michael C |
Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy
|
|
US9790282B2
(en)
|
2013-03-25 |
2017-10-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-CD276 polypeptides, proteins, and chimeric antigen receptors
|
|
CN104140974B
(zh)
|
2013-05-08 |
2017-09-29 |
科济生物医药（上海）有限公司 |
编码gpc‑3嵌合抗原受体蛋白的核酸及表达gpc‑3嵌合抗原受体蛋白的t淋巴细胞
|
|
EP3783098A1
(en)
*
|
2013-05-14 |
2021-02-24 |
Board Of Regents, The University Of Texas System |
Human application of engineered chimeric antigen receptor (car) t-cells
|
|
CA2913052A1
(en)
|
2013-05-24 |
2014-11-27 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptor-targeting monoclonal antibodies
|
|
ES2883131T3
(es)
|
2013-05-29 |
2021-12-07 |
Cellectis |
Métodos para la modificación de células T para inmunoterapia utilizando el sistema de nucleasa CAS guiado por ARN
|
|
ES2791598T3
(es)
|
2013-06-05 |
2020-11-05 |
Bellicum Pharmaceuticals Inc |
Métodos para inducir apoptosis parcial utilizando polipéptidos de caspasa
|
|
CA3051222C
(en)
|
2013-06-10 |
2023-01-24 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions for reducing immunosupression by tumor cells
|
|
BR112015032690B1
(pt)
|
2013-06-25 |
2020-03-10 |
Vaccinex, Inc. |
Uso de moléculas inibidoras de semaforina-4d em combinação com uma terapia imunomoduladora para inibir o crescimento tumoral e metástase
|
|
EP3027755B1
(en)
|
2013-08-02 |
2019-10-09 |
The Regents of The University of California |
Engineering antiviral t cell immunity through stem cells and chimeric antigen receptors
|
|
US11807675B2
(en)
|
2013-10-03 |
2023-11-07 |
The University Of Maryland, Baltimore |
Nanoparticle based artificial antigen presenting cell mediated activation of NKT cells
|
|
CN105813654B
(zh)
|
2013-10-11 |
2019-05-31 |
美国政府(由卫生和人类服务部的部长所代表) |
Tem8抗体及其用途
|
|
CN105829349B
(zh)
|
2013-10-15 |
2023-02-03 |
斯克利普斯研究所 |
肽嵌合抗原受体t细胞开关和其用途
|
|
US9931347B2
(en)
|
2013-12-03 |
2018-04-03 |
Iomet Pharma Ltd. |
Pharmaceutical compound
|
|
EP3077415B1
(en)
|
2013-12-06 |
2020-02-12 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Reduction of inflammatory disease symptoms by short peptides that inhibit signaling through cd28
|
|
WO2015127548A1
(en)
|
2014-02-28 |
2015-09-03 |
The Royal Institution For The Advancement Of Learning / Mcgill University |
Tc-ptp inhibitors as apc activators for immunotherapy
|
|
US20170335281A1
(en)
|
2014-03-15 |
2017-11-23 |
Novartis Ag |
Treatment of cancer using chimeric antigen receptor
|
|
PL3119807T3
(pl)
|
2014-03-19 |
2019-09-30 |
Cellectis |
Specyficzne wobec cd123 chimeryczne receptory antygenowe do immunoterapii nowotworów
|
|
CN106795221B
(zh)
|
2014-04-03 |
2022-06-07 |
塞勒克提斯公司 |
用于癌症免疫治疗的cd33特异性嵌合抗原受体
|
|
EP4166148B1
(en)
|
2014-06-06 |
2026-02-18 |
Memorial Sloan-Kettering Cancer Center |
Mesothelin-targeted chimeric antigen receptors and uses thereof
|
|
ES2806776T3
(es)
|
2014-06-18 |
2021-02-18 |
Chemotherapeutisches Forschungsinstitut Georg Speyer Haus |
Células NK-92 que expresan CAR como agentes terapéuticos celulares
|
|
TWI719942B
(zh)
|
2014-07-21 |
2021-03-01 |
瑞士商諾華公司 |
使用ｃｄ３３嵌合抗原受體治療癌症
|
|
PT3177640T
(pt)
|
2014-08-08 |
2020-08-31 |
Univ Leland Stanford Junior |
Agentes pd-1 de alta afinidade e métodos de utilização
|
|
MX2017002205A
(es)
|
2014-08-19 |
2017-08-21 |
Novartis Ag |
Receptor quimerico de antigeno (car) anti-cd123 para uso en el tratamiento de cancer.
|
|
DK4074735T3
(da)
|
2014-08-28 |
2025-07-14 |
Bioatla Inc |
Betinget aktive kimæriske antigenreceptorer til modificerede t-celler
|
|
BR112017005631A2
(pt)
*
|
2014-09-19 |
2018-06-26 |
City Of Hope |
células t com receptor de antígeno coestimulador quimérico direcionadas à il13ra2
|
|
US10016480B2
(en)
|
2014-10-14 |
2018-07-10 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
Peptide-based methods for treating pancreatic cancer
|
|
JP2017537622A
(ja)
|
2014-12-02 |
2017-12-21 |
ロジャー・ウィリアムズ・ホスピタル |
がんを治療するための方法及び組成物
|
|
PL3560953T3
(pl)
|
2014-12-24 |
2024-05-13 |
Autolus Limited |
Komórka
|
|
KR102624023B1
(ko)
|
2015-02-24 |
2024-01-11 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
결합-촉발된 전사 스위치 및 이들의 이용 방법
|
|
JP7237449B2
(ja)
|
2015-02-27 |
2023-03-13 |
アイセル・ジーン・セラピューティクス・エルエルシー |
血液系腫瘍を標的としたキメラ抗体受容体（ＣＡＲｓ）の構成およびその使用方法
|
|
WO2016138846A1
(en)
|
2015-03-02 |
2016-09-09 |
Shanghai Sidansai Biotechnology Co., Ltd |
Reducing immune tolerance induced by pd‐l1
|
|
WO2016161390A1
(en)
|
2015-04-03 |
2016-10-06 |
Eureka Therapeutics, Inc. |
Constructs targeting afp peptide/mhc complexes and uses thereof
|
|
JP6961490B2
(ja)
*
|
2015-04-08 |
2021-11-05 |
ノバルティス アーゲー |
Ｃｄ２０療法、ｃｄ２２療法、およびｃｄ１９キメラ抗原受容体（ｃａｒ）発現細胞との併用療法
|
|
US10786549B2
(en)
|
2015-04-23 |
2020-09-29 |
Baylor College Of Medicine |
CD5 chimeric antigen receptor for adoptive T cell therapy
|
|
GB201507111D0
(en)
|
2015-04-27 |
2015-06-10 |
Ucl Business Plc |
Nucleic acid construct
|
|
KR102349677B1
(ko)
|
2015-05-28 |
2022-01-12 |
카이트 파마 인코포레이티드 |
T 세포 요법을 위해 환자를 컨디셔닝하는 방법
|
|
ES2690420T3
(es)
|
2015-05-28 |
2018-11-20 |
Universität Zu Köln |
Receptor de antígeno quimérico anti-toso y su uso
|
|
US11154572B2
(en)
*
|
2015-06-05 |
2021-10-26 |
Board Of Regents, The University Of Texas System |
Methods of treatment with natural killer cells matched for killer immunoglobulin receptor type
|
|
US11655452B2
(en)
*
|
2015-06-25 |
2023-05-23 |
Icell Gene Therapeutics Inc. |
Chimeric antigen receptors (CARs), compositions and methods of use thereof
|
|
EP3322439A4
(en)
|
2015-07-16 |
2019-03-20 |
Prospect Chartercare RWMC LLC D/B/A Roger Williams Medical Center |
COMPOSITIONS AND METHOD FOR THE TREATMENT OF PERITONEAL CARCINOMA
|
|
GB2592821B
(en)
|
2015-07-31 |
2022-01-12 |
Univ Minnesota |
Modified cells and methods of therapy
|
|
ES2883240T3
(es)
|
2015-08-03 |
2021-12-07 |
Cafa Therapeutics Ltd |
Anticuerpo contra glipicano-3 y aplicación del mismo
|
|
WO2017027843A1
(en)
|
2015-08-12 |
2017-02-16 |
Massachusetts Institute Of Technology |
Cell surface coupling of nanoparticles
|
|
CA2939288A1
(en)
|
2015-08-28 |
2017-02-28 |
Rolls-Royce High Temperature Composites, Inc. |
Ceramic matrix composite including silicon carbide fibers in a ceramic matrix comprising a max phase compound
|
|
HK1258218A1
(zh)
|
2015-09-15 |
2019-11-08 |
Board Of Regents, The University Of Texas System |
T细胞受体(tcr)结合抗体及其应用
|
|
JP6816133B2
(ja)
|
2015-10-05 |
2021-01-20 |
プレシジョン バイオサイエンシズ，インク． |
改変ヒトｔ細胞受容体アルファ定常領域遺伝子を含む遺伝子改変細胞
|
|
US10508143B1
(en)
|
2015-10-30 |
2019-12-17 |
Aleta Biotherapeutics Inc. |
Compositions and methods for treatment of cancer
|
|
TWI724056B
(zh)
|
2015-11-19 |
2021-04-11 |
美商卡默森屈有限公司 |
Ｃｘｃｒ２抑制劑
|
|
TWI734715B
(zh)
|
2015-11-19 |
2021-08-01 |
美商卡默森屈有限公司 |
趨化因子受體調節劑
|
|
EP4212547A1
(en)
|
2015-12-03 |
2023-07-19 |
Juno Therapeutics, Inc. |
Modified chimeric receptors and related compositions and methods
|
|
WO2017093969A1
(en)
*
|
2015-12-04 |
2017-06-08 |
Novartis Ag |
Compositions and methods for immunooncology
|
|
EP3827838B1
(en)
|
2015-12-16 |
2023-06-07 |
The Walter and Eliza Hall Institute of Medical Research |
Inhibition of cytokine-induced sh2 protein in nk cells
|
|
IL260532B2
(en)
|
2016-01-11 |
2023-12-01 |
Univ Leland Stanford Junior |
Chimeric proteins- containing systems and uses thereof in regulating gene expression
|
|
MX2018008345A
(es)
|
2016-01-11 |
2018-12-06 |
Univ Leland Stanford Junior |
Proteínas quiméricas y métodos de inmunoterapia.
|
|
EP3988111A1
(en)
|
2016-04-01 |
2022-04-27 |
Innovative Cellular Therapeutics Holdings, Ltd. |
Use of chimeric antigen receptor modified cells to treat cancer
|
|
EP3475413B1
(en)
|
2016-06-22 |
2024-02-14 |
David Klatzmann |
Genetically modified t lymphocytes
|
|
CN109562126A
(zh)
*
|
2016-06-24 |
2019-04-02 |
美商生物细胞基因治疗有限公司 |
嵌合抗原受体(car)、组合物及其使用方法
|
|
CA3032838A1
(en)
|
2016-08-04 |
2018-02-08 |
Memorial Sloan-Kettering Cancer Center |
Compositions and methods for immunotherapy
|
|
AU2017347854B2
(en)
|
2016-10-27 |
2022-12-08 |
Intima Bioscience, Inc. |
Viral methods of T cell therapy
|
|
KR20210005240A
(ko)
*
|
2018-05-03 |
2021-01-13 |
보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
면역 관문 차단과 함께 키메라 항원 수용체를 발현하도록 가공된 천연 킬러 세포
|